Reicher, Lee
Shilo, Smadar https://orcid.org/0000-0003-2399-1866
Godneva, Anastasia
Lutsker, Guy
Zahavi, Liron https://orcid.org/0000-0001-8867-1287
Shoer, Saar https://orcid.org/0000-0003-0883-1434
Krongauz, David https://orcid.org/0000-0003-4017-1122
Rein, Michal
Kohn, Sarah https://orcid.org/0000-0001-9912-5935
Segev, Tomer
Schlesinger, Yishay https://orcid.org/0009-0009-4746-5677
Barak, Daniel
Levine, Zachary
Keshet, Ayya https://orcid.org/0000-0002-1841-7918
Shaulitch, Rotem
Lotan-Pompan, Maya
Elkan, Matan
Talmor-Barkan, Yeela
Aviv, Yaron
Dadiani, Maya https://orcid.org/0000-0002-1561-0755
Tsodyks, Yonatan
Gal-Yam, Einav Nili
Leibovitzh, Haim
Werner, Lael
Tzadok, Roie
Maharshak, Nitsan
Koga, Shin
Glick-Gorman, Yulia
Stossel, Chani
Raitses-Gurevich, Maria
Golan, Talia
Dhir, Raja
Reisner, Yotam https://orcid.org/0000-0001-9192-7167
Weinberger, Adina https://orcid.org/0000-0003-2231-4687
Rossman, Hagai
Song, Le
Xing, Eric P. https://orcid.org/0000-0002-3683-4280
Segal, Eran https://orcid.org/0000-0002-6859-1164
Article History
Received: 1 August 2024
Accepted: 23 May 2025
First Online: 15 July 2025
Competing interests
: Y.R., H.R. and Y.T.B are employees at Pheno.AI. A.K., A.W. and E.S. are paid consultants of Pheno.AI. N.M. has received speaking and consulting fees from Pfizer, Abbvie, Lilly, Takeda, Janssen, Ferring, BiomX, BMS, Nestle and Teva and grant support from Takeda, Janssen, Abbott, Abbvie, Pfizer, BMS, Corundum Innovation, Nestle and the Helmsely Charitable Trust. The other authors declare no competing interests.